Skip to main content
ORIENTAL AROMATICS LIMITED logo

ORIENTAL AROMATICS LIMITED — Investor Relations & Filings

Ticker · OAL ISIN · INE959C01023 LEI · 335800H8FLHTWT9G5311 BSE.NS Manufacturing
Filings indexed 1,491 across all filing types
Latest filing 2025-08-08 Regulatory Filings
Country IN India
Listing BSE.NS OAL

About ORIENTAL AROMATICS LIMITED

https://www.orientalaromatics.com/

Oriental Aromatics Limited specializes in the manufacture of aroma chemicals, camphor, fragrances, and flavors. The company operates an integrated business model, encompassing the production of terpene-based specialty chemicals and the creation of complex fragrance and flavor formulations. Its product portfolio includes synthetic camphor, isoborneol, terpineols, and various pine-based chemicals used in personal care, home care, and pharmaceutical applications. The company maintains advanced research and development facilities to innovate and customize scents and tastes for a global clientele. By leveraging its vertical integration, Oriental Aromatics ensures quality control from raw material processing to the final aromatic compounds, serving sectors such as cosmetics, detergents, and food processing.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2025-08-08 English
Intimation of conference call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2025-08-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is an invitation to a conference call to discuss Q1-FY26 earnings of Oriental Aromatics Ltd. It includes details about the date, time, management participants, dial-in numbers, and links to join the call. There is no actual financial data or detailed financial report included, only an announcement of the earnings call event. Therefore, this document is best classified as a Call Transcript (CT) category, as it relates to the earnings conference call. Confidence is high because the document explicitly states it is an earnings conference call invite.
2025-08-06 English
Oriental Aromatics Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve 1. Consider and approve ....
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges (BSE and NSE) about an upcoming Board Meeting scheduled for 8th August 2025. The purpose of the meeting includes considering and approving the unaudited standalone and consolidated financial results for the quarter ended 30th June 2025. It also mentions the closure of the trading window as per SEBI regulations. The document is short (2169 characters) and serves as an intimation or announcement about the Board Meeting and the forthcoming financial results, not the financial results report itself. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as a general regulatory announcement and compliance notice under SEBI regulations.
2025-08-01 English
Board Meeting — ORIENTAL AROMATICS LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company fo…
Regulatory Filings
2025-08-01 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges (BSE and NSE) informing about an upcoming Board Meeting scheduled for 8th August 2025. The purpose of the meeting includes consideration and approval of the unaudited standalone and consolidated financial results for the quarter ended 30th June 2025. The document also mentions the closure of the trading window as per SEBI regulations. The document is short (2169 characters) and serves as an intimation or announcement about the Board Meeting and the forthcoming financial results, not the financial results report itself. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as a general announcement under SEBI regulations about the Board Meeting and financial results approval.
2025-08-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.